155
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries

ORCID Icon, , , , , ORCID Icon, , , , , , & show all
Pages 423-433 | Published online: 01 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eladio Fernández-Liz, Pere Vivó-Tristante, Antonio Aranzana-Martínez, Maria Estrella Barceló-Colomer, Maria Larrosa-Garcia, José Luís del Val García & Elisabeth Martín-Gracia. (2021) Long-term effectiveness of an intervention to enhance mirabegron use revision and its deprescribing: 36-month follow-up of a quasi-experimental trial in primary care. Current Medical Research and Opinion 37:4, pages 703-710.
Read now

Articles from other publishers (2)

Man Yang, Qiangsheng He, Fang Gao, Krish Nirantharakumar, Tonny Veenith, Xiwen Qin, Amy T. Page, Martin C. S. Wong, Junjie Huang, Zi Chong Kuo, Bin Xia, Changhua Zhang, Yulong He, Wenbo Meng, Jinqiu Yuan & Yihang Pan. (2021) Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials. BMC Medicine 19:1.
Crossref
Veena Hoffman, Jesper Hallas, Marie Linder, Andrea V. Margulis, Brandon T. Suehs, Alejandro Arana, Kelesitse Phiri, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susana Perez-Gutthann, Yihua Xu, Nina Sahlertz Kristiansen, Kwame Appenteng, Stefan de Vogel, John D. Seeger, Cheryl Enger, John Seeger, Veena Hoffman, Kelesitse Phiri, Jesper Hallas, Morten Olesen, Nina Sahlertz Kristiansen, Shahram Bahmanyar, Marie Linder, Helle Kieler, Ingvild Odsbu, Alejandro Arana, Lisa McQuay, Andrea Margulis, Susana Perez-Gutthann, Ryan Ziemiecki, Su Bunniran, Brandon Suehs, Claudia Uribe, Yihua Xu, Libby Horter, Kwame Appenteng, Stefan de Vogel, Noah Jamie Robinson, Songlin Xue, Josie Wolfram, Achim Steup, Jena Giese-Pagac, Raymond van Aarle, Neha Sheth, David Burns, Natalie Boone, Mary Beth Blauwet, Milbhor D’Silva, Billy Franks, Willem Jan Atsma, Tim Auton, Edeltraut Garbe, Anders Ekbom, Todd Lee, Noel Weiss, John Rumsfeld, Sara Yuewen Gao, Laura Karslake, Nan Liu, Katherine Reed, Bruce Turnbull, Jing Yang, Nicole Brooks & Kathleen Mortimer. (2021) Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug Safety 44:8, pages 899-915.
Crossref